Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Int J Public Health ; 69: 1606684, 2024.
Article in English | MEDLINE | ID: mdl-38528851

ABSTRACT

Objectives: As there is no ranking designed for schools of Public Health, the aim of this project was to create one. Methods: To design the Public Health Academic Ranking (PHAR), we used the InCites Benchmarking and Analytics™ software and the Web Of Science™ Core Collection database. We collected bibliometric data on 26 schools of Public Health from each continent, between August and September 2022. We included 11 research indicators/scores, covering four criteria (productivity, quality, accessibility for readers, international collaboration), for the period 2017-2021. For the Swiss School of Public Health (SSPH+), a network gathering faculties across different universities, a specific methodology was used, with member-specific research queries. Results: The five top schools of the PHAR were: London School of Hygiene and Tropical Medicine, Public Health Foundation of India, Harvard T.H. Chan School of Public Health, SSPH+, Johns Hopkins Bloomberg School of Public Health. Conclusion: The PHAR allows worldwide bibliometric ordering of schools of Public Health. As this is a pilot project, the results must be taken with caution. This article aims to critically discuss its methodology and future improvements.


Subject(s)
Public Health , Schools , Humans , Public Health/education , Pilot Projects , Universities , Hygiene
2.
Front Psychiatry ; 14: 1181767, 2023.
Article in English | MEDLINE | ID: mdl-37351002

ABSTRACT

SARS-CoV-2 is a growing field of research and mental health in long COVID is one of its interesting domains. This scoping review aims at studying the outcomes of mental health in patients already known for psychiatric illness. This was done by researching the literature in two databases (Embase and PubMed) for articles studying mental health consequences of long COVID in patients already known for psychiatric history. Eleven studies were included. 6/11 studies found an effect of long COVID, with varying severity of outcomes studied, with either a worsening in length or severity. 4/11 did not find any correlation between worsening symptoms and psychiatric history. The methods for assessing which psychiatric symptoms to include and how to determine prior history were heterogeneous, making direct comparison sometimes difficult. The data seem to show worse effects of long COVID on mental health of patients with prior mental illness, with limitations regarding the heterogeneity of the studies' designs and focuses. It also highlights how neglected this population of patients is in the current state of research.

3.
Sci Rep ; 13(1): 8729, 2023 05 30.
Article in English | MEDLINE | ID: mdl-37253848

ABSTRACT

No study has yet investigated if a severe SARS-CoV-2 infection represents a marker of an undiagnosed cancer. This population-based study, using the SNDS database, identified from 02/15/2020 to 08/31/2021, 41,302 individuals hospitalized in intensive care unit due to SARS-CoV-2 (ICU-gr) and 713,670 control individuals not hospitalized for SARS-CoV-2 (C-gr). Individuals were matched according to year of birth, sex and French department. The cancer incidence was compared in the two groups during the follow-up period (index date-12/31/2021), using Cox proportional hazards models adjusted on matching variables, socioeconomic characteristics and comorbidities. In the ICU-gr, 2.2% (n = 897) was diagnosed with a cancer in the following months, compared to 1.5% (n = 10,944) in the C-gr. The ICU-gr had a 1.31 higher risk of being diagnosed with a cancer following hospital discharge compared to the C-gr (aHR 1.31, 95% CI 1.22-1.41). A global similar trend was found when competing risk of death was taken into account (aHR 1.25, 95% CI 1.16-1.34). A significant higher risk was found concerning renal (aHR 3.16, 95% CI 2.33-4.27), hematological (aHR 2.54, 95% CI 2.07-3.12), colon (aHR 1.72, 95% CI 1.34-2.21), and lung (aHR 1.70, 95% CI 1.39-2.08) cancers. This suggests that a severe SARS-CoV-2 infection may represent a marker of an undiagnosed cancer.


Subject(s)
COVID-19 , Neoplasms , Humans , COVID-19/diagnosis , COVID-19/epidemiology , Neoplasms/diagnosis , Neoplasms/epidemiology , SARS-CoV-2 , Undiagnosed Diseases
4.
Public Health Rev ; 44: 1605803, 2023.
Article in English | MEDLINE | ID: mdl-38273885

ABSTRACT

Objectives: The COVID-19 pandemic has been a major public health concern for the past 3 years. Scientific evidence on the relationship between SARS-CoV-2 infection and indoor air quality still needs to be demonstrated. This scoping review aims to study the association between air quality indoors and COVID-19. Methods: A scoping review analyzing the association between indoor air quality and epidemiological outcomes was conducted. Papers published between 1 January 2020 and 31 October 2022 were included. Hospital settings were excluded from the study. Results: Eight relevant articles met the inclusion criteria. Indoor settings included workplaces, schools, restaurants, and public transport. Types of ventilation used to improve indoor air quality were dilution methods (opening windows) and mechanical systems with or without filtration or purifier. CO2 sensors were employed in one study. All the studies showed a positive association between indoor air quality and its improvement and epidemiological indicators. Conclusion: The findings of this scoping review indicate that indoor air quality, which can be improved with ventilation methods, may reduce the risk of developing COVID-19. Ventilation could thus be viewed as a possible effective mitigating method.

9.
Rev Med Suisse ; 16(708): 1790-1795, 2020 Sep 30.
Article in French | MEDLINE | ID: mdl-32997448

ABSTRACT

Medical care of adults with disabilities, especially those with intellectual disabilities, can be ethically difficult. Several questions arise frequently. Can we administer a life-saving treatment that could impact negatively the patient's quality of life when the patient isn't able to give consent? During this Covid-19 period, can the use of chemical or physical restraints be considered as mistreatment, whereas the aim is to protect others? These are situations where the ethical question holds a central role. Although each clinical situation is unique, this article highlights, through four clinical cases, the ethical principles that should guide physicians in their decision-making process.


La prise en charge médicale des adultes en situation de handicap, notamment ceux souffrant de déficience mentale, peut se révéler difficile d'un point de vue éthique. Plusieurs questions se posent fréquemment. Peut-on proposer un traitement vital mais qui risque d'impacter la qualité de vie du patient sans pouvoir obtenir son consentement ? En période de Covid-19, l'utilisation de moyens de contention chimique ou physique peut-elle être considérée comme de la maltraitance alors qu'on cherche à protéger autrui ? Autant de situations où la question éthique prend une place centrale. Si chaque cas est évidemment différent, nous vous proposons, à travers quatre vignettes cliniques, de mettre en lumière les principes éthiques accompagnant le médecin dans son processus décisionnel.


Subject(s)
Clinical Decision-Making/ethics , Coronavirus Infections/psychology , Coronavirus Infections/therapy , Disabled Persons , Intellectual Disability , Pneumonia, Viral/psychology , Pneumonia, Viral/therapy , Quality of Life , Adult , COVID-19 , Coronavirus Infections/epidemiology , Humans , Informed Consent/ethics , Pandemics , Pneumonia, Viral/epidemiology , Restraint, Physical/ethics
10.
Int J Gynaecol Obstet ; 132(2): 174-8, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26493013

ABSTRACT

OBJECTIVE: To study the obstetric outcomes of women attending a specialized clinic for women with female genital mutilation (FGM). METHODS: The medical charts of women with FGM who consecutively attended a specialized clinic between 2010 and 2012 were reviewed retrospectively. The present study focused on women attending for obstetric reasons. The outcome measures were type of delivery, reason for cesarean delivery or assisted delivery, blood loss, episiotomy, perineal tear, duration of the second stage of labor, postpartum complications, weight of the neonate, and Apgar score. Outcomes were compared between women with FGM type III who underwent defibulation, and patients with FGM type I and II. RESULTS: The clinic was attended by 129 women, 84 perinatally. Obstetric outcomes were similar to average outcomes for women without FGM presenting at the same department and in Switzerland generally. Specifically, 20 women had a cesarean delivery. An assisted delivery was performed for 18 patients; among these, only eight had experienced obstructed labor. No statistically significant differences were found for the outcome measures when women with FGM type III were compared to FGM type I and II. CONCLUSIONS: Routine obstetric follow-up combined with specialized care for women with FGM, including defibulation, can avoid inappropriate obstetric practices and reduce obstetric complications known to be associated with FGM.


Subject(s)
Circumcision, Female/adverse effects , Delivery, Obstetric/methods , Obstetric Labor Complications/etiology , Adolescent , Adult , Apgar Score , Birth Weight , Cesarean Section/statistics & numerical data , Episiotomy/statistics & numerical data , Female , Humans , Infant, Newborn , Labor, Obstetric , Postpartum Hemorrhage/etiology , Pregnancy , Pregnancy Outcome , Retrospective Studies , Switzerland , Tertiary Care Centers , Young Adult
11.
Int J Gynaecol Obstet ; 125(3): 256-60, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24713414

ABSTRACT

OBJECTIVE: To investigate missed opportunities for diagnosing female genital mutilation (FGM) at an obstetrics and gynecology (OB/GYN) department in Switzerland. METHODS: In a retrospective study, we included 129 consecutive women with FGM who attended the FGM outpatient clinic at the Department of Gynecology and Obstetrics at the University Hospitals of Geneva between 2010 and 2012. The medical files of all women who had undergone at least 1 previous gynecologic exam performed by an OB/GYN doctor or a midwife at the study institution were reviewed. The type of FGM reported in the files was considered correct if it corresponded to that reported by the specialized gynecologist at the FGM clinic, according to WHO classification. RESULTS: In 48 (37.2%) cases, FGM was not mentioned in the medical file. In 34 (26.4%) women, the diagnosis was correct. FGM was identified but erroneously classified in 28 (21.7%) cases. There were no factors (women's characteristics or FGM type) associated with missed diagnosis. CONCLUSION: Opportunities to identify FGM are frequently missed. Measures should be taken to improve FGM diagnosis and care.


Subject(s)
Circumcision, Female/statistics & numerical data , Diagnostic Errors/statistics & numerical data , Gynecology/standards , Obstetrics/standards , Adolescent , Adult , Child , Child, Preschool , Circumcision, Female/classification , Female , Humans , Infant , Outpatient Clinics, Hospital , Retrospective Studies , Switzerland , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...